A phase 2 trial shows combining intravesical recombinant BCG with chemoimmunotherapy in MIBC yields a higher than expected pathologic complete response rate. Intravesical recombinant bacillus Calmette ...
Julia is the associate news editor for Health, where she edits and publishes news articles on trending health and wellness topics. Her work has been featured in The Heights, an independent student ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results